[HTML][HTML] Targeting myeloid-derived suppressor cells in tumor immunotherapy: Current, future and beyond

Y Zhao, J Du, X Shen - Frontiers in Immunology, 2023 - frontiersin.org
Myeloid-derived suppressor cells (MDSCs) are one of the major negative regulators in tumor
microenvironment (TME) due to their potent immunosuppressive capacity. MDSCs are the …

Targeting myeloid-derived suppressor cells in tumor immunotherapy: Current, future and beyond

Y Zhao, J Du, X Shen - Frontiers in Immunology, 2023 - europepmc.org
Myeloid-derived suppressor cells (MDSCs) are one of the major negative regulators in tumor
microenvironment (TME) due to their potent immunosuppressive capacity. MDSCs are the …

[HTML][HTML] Targeting myeloid-derived suppressor cells in tumor immunotherapy: Current, future and beyond

Y Zhao, J Du, X Shen - Frontiers in Immunology, 2023 - ncbi.nlm.nih.gov
Myeloid-derived suppressor cells (MDSCs) are one of the major negative regulators in tumor
microenvironment (TME) due to their potent immunosuppressive capacity. MDSCs are the …

[引用][C] Targeting myeloid-derived suppressor cells in tumor immunotherapy: Current, future and beyond

Y Zhao, X Shen - Frontiers in Immunology (Web), 2023 - jglobal.jst.go.jp
Targeting myeloid-derived suppressor cells in tumor immunotherapy: Current, future and
beyond | Article Information | J-GLOBAL Art J-GLOBAL ID:202302214310831873 …

Targeting myeloid-derived suppressor cells in tumor immunotherapy: Current, future and beyond

Y Zhao, J Du, X Shen - Frontiers in immunology, 2023 - pubmed.ncbi.nlm.nih.gov
Myeloid-derived suppressor cells (MDSCs) are one of the major negative regulators in tumor
microenvironment (TME) due to their potent immunosuppressive capacity. MDSCs are the …